Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Buy
4,149
+204
+5% +$43.9K 0.2% 76
2026
Q1
$858K Sell
3,945
-24
-0.6% -$5.32K 0.18% 80
2025
Q4
$907K Sell
3,969
-1
-0% -$228 0.18% 77
2025
Q3
$919K Hold
3,970
0.2% 75
2025
Q2
$737K Sell
3,970
-3
-0.1% -$558 0.17% 82
2025
Q1
$832K Sell
3,973
-77
-2% -$15K 0.2% 76
2024
Q4
$720K Buy
4,050
+1,181
+41% +$217K 0.17% 83
2024
Q3
$567K Sell
2,869
-339
-11% -$63.3K 0.13% 95
2024
Q2
$550K Sell
3,208
-117
-4% -$19.4K 0.14% 92
2024
Q1
$605K Sell
3,325
-1,163
-26% -$200K 0.15% 91
2023
Q4
$696K Sell
4,488
-26
-0.6% -$3.79K 0.18% 85
2023
Q3
$673K Sell
4,514
-19
-0.4% -$2.79K 0.19% 79
2023
Q2
$611K Sell
4,533
-73
-2% -$10.7K 0.17% 86
2023
Q1
$734K Sell
4,606
-213
-4% -$32.6K 0.22% 77
2022
Q4
$779K Sell
4,819
-895
-16% -$137K 0.24% 75
2022
Q3
$767K Buy
5,714
+45
+0.8% +$6.46K 0.23% 72
2022
Q2
$869K Buy
5,669
+196
+4% +$29.9K 0.25% 68
2022
Q1
$887K Buy
5,473
+90
+2% +$13.1K 0.21% 74
2021
Q4
$729K Hold
5,383
0.16% 85
2021
Q3
$581K Sell
5,383
-150
-3% -$17.1K 0.14% 88
2021
Q2
$623K Sell
5,533
-164
-3% -$18.5K 0.15% 89
2021
Q1
$616K Sell
5,697
-256
-4% -$27.4K 0.15% 90
2020
Q4
$638K Sell
5,953
-1,036
-15% -$99.6K 0.16% 85
2020
Q3
$612K Buy
+6,989
New +$658K 0.16% 85

Other funds holding ABBV

Berkshire Bank's ABBV Position: Q2 2026 in Review

Berkshire Bank increased its AbbVie (ABBV) stake by 5.2% in Q2 2026, buying an estimated $43.9K and bringing the position to 4,149 shares worth $1.04M. The position accounts for 0.2% of the portfolio, ranked #76.

Berkshire Bank first reported a position in ABBV in Q3 2020 and has held it in 24 quarters since. 2,233 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Berkshire Bank held 4,149 shares of AbbVie worth $1.04M as of Q2 2026.
  • Berkshire Bank bought 204 AbbVie shares in Q2 2026, an estimated $43.9K.
  • AbbVie made up 0.2% of Berkshire Bank's portfolio in Q2 2026, its #76 holding.
  • Berkshire Bank first reported a position in AbbVie in Q3 2020 and has held it in 24 quarters since.
  • 2,233 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Berkshire Bank's 13F filing for Q2 2026, filed 8 Jul 2026.